Yuksel Peker

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up
    Yuksel Peker
    Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Respir Crit Care Med 166:159-65. 2002
  2. ncbi Obstructive apneic events induce alpha-receptor mediated digital vasoconstriction
    Ding Zou
    Sleep Laboratory, Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Sleep 27:485-9. 2004
  3. ncbi Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography
    Ding Zou
    Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Sleep 29:367-74. 2006
  4. ncbi A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathing
    Stefan Torvaldsson
    Sleep Laboratory, Department of Allergology and Pulmonary Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    J Sleep Res 14:149-55. 2005
  5. pmc Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity
    Mahssa Karimi
    Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    J Clin Sleep Med 6:256-63. 2010
  6. ncbi [Sleep apnea a risk factor of cardiovascular disease]
    Yuksel Peker
    Sömnlaboratoriet, avdelningen för lungmedicin och allergologi, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 99:4473-9. 2002
  7. doi Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea--RICCADSA trial
    Yuksel Peker
    Sleep Medicine Unit, Department of Neurology and Rehabilitation Medicine, Skaraborg Hospital, Skovde, Sweden
    Scand Cardiovasc J 43:24-31. 2009
  8. ncbi Reduction of sleep-disordered breathing after physostigmine
    Jan Hedner
    Sleep Laboratory, Department of Pulmonary Medicine and Allergology, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Am J Respir Crit Care Med 168:1246-51. 2003

Detail Information

Publications8

  1. ncbi Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up
    Yuksel Peker
    Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Respir Crit Care Med 166:159-65. 2002
    ..Furthermore, efficient treatment of OSA reduces the excess CVD risk and may be considered also in relatively mild OSA without regard to daytime sleepiness...
  2. ncbi Obstructive apneic events induce alpha-receptor mediated digital vasoconstriction
    Ding Zou
    Sleep Laboratory, Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Sleep 27:485-9. 2004
    ..To characterize the role of alpha-receptors in autonomic control of digital skin blood flow change in response to obstructive apnea-hypopnea events...
  3. ncbi Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography
    Ding Zou
    Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Sleep 29:367-74. 2006
    ..To propose a new standard for limited-channel device validation using synchronized polysomnography (PSG) home recordings and a population-based cohort...
  4. ncbi A randomized placebo-controlled trial of an NMDA receptor antagonist in sleep-disordered breathing
    Stefan Torvaldsson
    Sleep Laboratory, Department of Allergology and Pulmonary Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    J Sleep Res 14:149-55. 2005
    ..The previously postulated role of glutamate in SDB could not be confirmed after AR-R15896AR induced NMDA-receptor blockade...
  5. pmc Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity
    Mahssa Karimi
    Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    J Clin Sleep Med 6:256-63. 2010
    ..OSA is associated with both growth hormone (GH) excess and severe GH deficiency in adults. Adults with abdominal obesity have markedly suppressed GH secretion...
  6. ncbi [Sleep apnea a risk factor of cardiovascular disease]
    Yuksel Peker
    Sömnlaboratoriet, avdelningen för lungmedicin och allergologi, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 99:4473-9. 2002
    ..Continuous intense research into pathophysiological mechanisms and therapeutic possibilities of CVD related to OSA appears to be an important and potentially rewarding area of disease prevention...
  7. doi Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea--RICCADSA trial
    Yuksel Peker
    Sleep Medicine Unit, Department of Neurology and Rehabilitation Medicine, Skaraborg Hospital, Skovde, Sweden
    Scand Cardiovasc J 43:24-31. 2009
    ..To date, there is a lack of randomized controlled trials to draw the conclusion that all CAD patients should be investigated for OSA and subsequently be treated with continuous positive airway pressure (CPAP)...
  8. ncbi Reduction of sleep-disordered breathing after physostigmine
    Jan Hedner
    Sleep Laboratory, Department of Pulmonary Medicine and Allergology, Sahlgrenska University Hospital, S 413 45 Goteborg, Sweden
    Am J Respir Crit Care Med 168:1246-51. 2003
    ..77, p < 0.02). This, predominantly REM-related, reduction of obstructive sleep apnea after PHYS may provide a new treatment option if the effects are maintained in long-term studies...